Found: 9
Select item for more details and to access through your institution.
Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00142
- By:
- Publication type:
- Article
Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2012, v. 2, p. 1, doi. 10.3389/fonc.2012.00142
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-58
- By:
- Publication type:
- Article
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-30
- By:
- Publication type:
- Article
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-riskp rostate cancer.
- Published in:
- Journal of Hematology & Oncology, 2011, v. 4, n. 1, p. 12, doi. 10.1186/1756-8722-4-12
- By:
- Publication type:
- Article
CyberKnife® enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures.
- Published in:
- Journal of Hematology & Oncology, 2010, v. 3, p. 22, doi. 10.1186/1756-8722-3-22
- By:
- Publication type:
- Article
Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 15, p. 3681, doi. 10.1002/cncr.26699
- By:
- Publication type:
- Article